63618-36-0 Usage
Uses
Used in Medical and Veterinary Settings:
2-(DIMETHYLAMINO)-N,N-DIETHYLACETAMIDE is used as an anesthetic and sedative agent for inducing a state of temporary insensibility to pain, particularly during minor surgical procedures. Its ability to block nerve impulse transmission makes it a valuable component in medical and veterinary practices.
Used in Pharmaceutical Formulations:
In the pharmaceutical industry, 2-(DIMETHYLAMINO)-N,N-DIETHYLACETAMIDE is used as an active ingredient in topical anesthetic creams and ointments. It provides localized pain relief and is suitable for treating various conditions that require surface-level analgesia.
Used in Research Applications:
2-(DIMETHYLAMINO)-N,N-DIETHYLACETAMIDE is utilized as a solvent and reagent in research settings. Its chemical properties make it a versatile component in conducting a variety of chemical reactions, contributing to the advancement of scientific knowledge and the development of new compounds and materials.
Safety Precautions:
Due to the sedative and anesthetic properties of 2-(DIMETHYLAMINO)-N,N-DIETHYLACETAMIDE, it is crucial to handle and store this chemical with care. Adherence to safety guidelines is necessary to prevent unintended exposure or accidents, ensuring the well-being of individuals who come into contact with 2-(DIMETHYLAMINO)-N,N-DIETHYLACETAMIDE.
Check Digit Verification of cas no
The CAS Registry Mumber 63618-36-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,6,1 and 8 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 63618-36:
(7*6)+(6*3)+(5*6)+(4*1)+(3*8)+(2*3)+(1*6)=130
130 % 10 = 0
So 63618-36-0 is a valid CAS Registry Number.
63618-36-0Relevant academic research and scientific papers
Quaternary ammonium salt type honokiol/magnolol derivative as well as preparation method and application thereof
-
Paragraph 0039; 0050-0051, (2021/06/26)
The invention discloses a series of novel quaternary ammonium salt honokiol/magnolol derivatives as well as a preparation method and application thereof. According to the series of compounds, honokiol/magnolol is taken as a raw material, a series of novel quaternary ammonium salt honokiol/magnolol derivatives are prepared on phenolic hydroxyl groups of honokiol/magnolol through a coupling reaction, and the structural general formula is shown in the specification. The compound disclosed by the invention has very strong antibacterial activity on staphylococcus aureus ATCC 29213 and clinically separated methicillin-resistant staphylococcus aureus (MRSA), most of the derivatives are higher than parent honokiol/magnolol, and the activity of part of the target derivatives is higher than that of a contrast drug levofloxacin. The compound is expected to be used for preparing drugs for resisting staphylococcus aureus and methicillin-resistant staphylococcus aureus.
